Accuray reported $110.02M in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbott ABT:US $ 11257M 638M
Accuray ARAY:US $ 110.02M 13.85M
Atricure ATRC:US $ 84.53M 9.95M
Boston Scientific BSX:US $ 3244M 218M
Cardiovascular Systems CSII:US $ 62.5M 6.28M
Cryolife CRY:US $ 80.34M 3.13M
Edwards Lifesciences EW:US $ 1373.9M 32.7M
Hologic HOLX:US $ 1002.7M 433M
Inogen INGN:US $ 103.38M 22.99M
Mesa Laboratories MLAB:US $ 50.45M 8.43M
Natus Medical BABY:US $ 119.79M 8.86M
Orthofix International OFIX:US $ 118.07M 11.65M
Surmodics SRDX:US $ 24.85M 1.25M
Tandem Diabetes Care TNDM:US $ 200.26M 24.36M
Trinity Biotech TRIB:US $ 18.78M 0.75M